Posted inDrug Development
What I learned from FDA interactions
Key takeaways: Preparation and understanding the FDA team are crucial for successful interactions, fostering rapport and…
Posted inDrug Development
What I learned from industry collaborations
Key takeaways: Collaboration fosters innovation and builds trust, leading to unexpected breakthroughs through shared goals and…
Posted inDrug Development
What I learned about patient adherence strategies
Key takeaways: Personalizing treatment plans and incorporating emotional support significantly enhance patient adherence, as individualized strategies…
Posted inDrug Development
What I learned about biomarkers
Key takeaways: Biomarkers serve as crucial biological indicators, aiding in personalized medicine by revealing individual physiological…
Posted inDrug Development
What I discovered about end-of-study reporting
Key takeaways: End-of-study reports are essential for sharing insights, guiding future research, and demonstrating accountability, often…
Posted inDrug Development
What I discovered about ethics in research
Key takeaways: Research ethics play a critical role in protecting participants and ensuring the integrity of…
Posted inDrug Development
What I discovered about intellectual property issues
Key takeaways: Understanding intellectual property rights (IPR) is essential for creators to protect their inventions, artworks,…
Posted inDrug Development
What I discovered about pharmacokinetics
Key takeaways: Pharmacokinetics comprises four key phases: absorption, distribution, metabolism, and excretion, each influencing drug effectiveness…
Posted inDrug Development
What I discovered about drug repurposing
Key takeaways: Drug repurposing offers swift treatment options and cost reductions by utilizing existing medications for…
Posted inDrug Development
My thoughts on virtual clinical trials
Key takeaways: Virtual clinical trials enhance patient convenience and engagement by allowing participation from home, thus…